Clinical trial
Exogenous and Endogenous Biomarkers of CYP2D6 and CYP3A4 Variability in Pediatrics
NCT01118858 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exogenous and Endogenous Biomarkers of CYP2D6 and CYP3A4 Variability in Pediatrics
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- October 31, 2015
- Enrollment
- 205 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
drug metabolism phenotype